Celldex Therapeutics CLDX Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

PfizerPFE

6%—

Rogers CorporationROG

-4.6%-9.0pp

AmgenAMGN

14.8%+3.6pp

Regeneron PharmaceuticalsREGN

10.3%-1.5pp

IncyteINCY

62.6%+24.7pp

FAQ

What is Celldex Therapeutics's return on invested capital?

Celldex Therapeutics (CLDX) reported return on invested capital of -49.8% in Q2 2026.

How has Celldex Therapeutics's return on invested capital changed year-over-year?

Celldex Therapeutics's return on invested capital decreased by 49.6% year-over-year, from -33.3% to -49.8%.

What is the long-term trend for Celldex Therapeutics's return on invested capital?

Over 5 years (2020 to 2025), Celldex Therapeutics's return on invested capital has grown at a -1.1% compound annual growth rate (CAGR), from -49.6% to -47%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.